Latest News and Press Releases

MONTREAL, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that pharmacokinetic data from the pivotal phase III clinical trial for...

MONTRÉAL, 03 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que des données pharmacocinétiques provenant de l’étude pivot de phase...

MONTRÉAL, 28 sept. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) a annoncé aujourd’hui avoir été informée par Lyne Fortin, vice-présidente sénior et chef de la...

MONTREAL, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it was informed by Lyne Fortin, Senior Vice President and Chief Commercial...

MONTREAL, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended August 31,...

MONTRÉAL, 27 sept. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. («Theratechnologies») (TSX : TH) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers jeudi le 4 octobre 2018...

MONTREAL, Quebec, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial...

MONTRÉAL, Québec, 27 sept. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX : TH) est heureuse d’annoncer que Philippe Dubuc, vice-président senior et chef de la...

MONTREAL, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the European Medicines Agency (“EMA”) has confirmed the validity of the...

MONTRÉAL, 14 sept. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que l’Agence européenne des médicaments (« AEM ») a confirmé la validité...